Trending...
- Chicago: Mayor Brandon Johnson Celebrates 10-Year Anniversary Of Dyett High School Hunger Strike
- "Leading From Day One: The Essential Guide for New Supervisors" Draws from 25+ Years of International Management Experience
- Prostate Cancer Survivor's Podcast Grows Audience And Builds Marketing Muscle
TAMPA, Fla. - illiNews -- Juventix Regenerative Medical, a leader in regenerative medicine solutions, proudly announces that its Platelet-Rich Plasma (PRP) technology has been featured in a groundbreaking university-published research study. The study, titled "Platelet-Rich Plasma for Rheumatoid Arthritis: A Case Series", published in the peer-reviewed journal Cureus, underscores the efficacy of Juventix PRP in managing rheumatoid arthritis, showcasing its transformative potential in clinical applications.
The study explores the use of PRP to address inflammation and improve outcomes in rheumatoid arthritis patients, with findings demonstrating measurable benefits attributed to Juventix PRP's advanced process. The research highlights the role of PRP in promoting tissue repair and reducing joint pain, offering a promising non-surgical alternative for patients seeking regenerative therapies.
Scientific Validation Backed by Laboratory Studies
Juventix PRP's inclusion in this research aligns with findings from extensive laboratory evaluations conducted by BioSciences Research Associates (2020) and Biofyl Scientific Research (2023). Key results include:
More on illi News
Special Offer for Medical Practitioners
To introduce clinicians to its cutting-edge PRP systems, Juventix is offering a sample PRP kit for only $20. This limited-time opportunity enables practitioners to experience the proven quality of Juventix PRP firsthand.
• Email: hello@juventix.com with the subject line "SAMPLE"
• Visit: https://juventix.com/sample-page/
About Juventix Regenerative Medical, LLC
Founded in 2017 by Lance Liberti, Juventix Regenerative Medical has been a pioneer in non-surgical regenerative solutions, including FDA-cleared PRP kits. The company offers comprehensive products such as centrifuges, LED activators, and bio-incubators to support superior PRP preparation. Juventix also collaborates with prestigious organizations, including the University of South Florida (USF) Health Center for Advanced Medical Learning and Simulation (CAMLS), to host advanced clinical training symposiums.
For more information, visit www.Juventix.com or contact:
More on illi News
📞 (866) 693-4777
✉️ Email: hello@juventix.com
Restore, Revive, Regenerate – Juventix Regenerative Medical.
The study explores the use of PRP to address inflammation and improve outcomes in rheumatoid arthritis patients, with findings demonstrating measurable benefits attributed to Juventix PRP's advanced process. The research highlights the role of PRP in promoting tissue repair and reducing joint pain, offering a promising non-surgical alternative for patients seeking regenerative therapies.
Scientific Validation Backed by Laboratory Studies
Juventix PRP's inclusion in this research aligns with findings from extensive laboratory evaluations conducted by BioSciences Research Associates (2020) and Biofyl Scientific Research (2023). Key results include:
- 84% platelet recovery, significantly enhancing platelet-derived growth factor (PDGF) concentrations.
- 10x increase in PDGF levels, with treated PRP reaching 10,844 pg/mL compared to 1,536 pg/mL in untreated samples.
- Minimal contamination of red and white blood cells, ensuring safety and reducing inflammatory risks.
- Optimized pH of 7.5, creating an ideal environment for platelet activation and growth factor release.
- Innovative activation methods, including photoactivation and bio-incubation, transforming PRP into PRF for versatile clinical applications.
More on illi News
- Cars.com Names Top EV Picks as Nearly 50% of Shoppers Accelerate Purchases Ahead of Federal EV Tax Credit Expiration Sept. 30 USA - English USA - English
- Open Art Call | The Art of Artificial Intelligence | Copenhagen
- Premieres of 10th Annual NY Dog Film Festival & 8th Annual NY Cat Film Festival on Sunday, October 26, 2025 to Benefit Animal Lighthouse Rescue
- $20 Price Target in Noble Capital Research Report as Deal is Signed for NFL Yearbook Advertising Across 25 Stadiums for AI Powered Sports Leader $SEGG
- 3E Launches First AI Agent Designed to Respond with Empathy for College Recruitment
Special Offer for Medical Practitioners
To introduce clinicians to its cutting-edge PRP systems, Juventix is offering a sample PRP kit for only $20. This limited-time opportunity enables practitioners to experience the proven quality of Juventix PRP firsthand.
• Email: hello@juventix.com with the subject line "SAMPLE"
• Visit: https://juventix.com/sample-page/
About Juventix Regenerative Medical, LLC
Founded in 2017 by Lance Liberti, Juventix Regenerative Medical has been a pioneer in non-surgical regenerative solutions, including FDA-cleared PRP kits. The company offers comprehensive products such as centrifuges, LED activators, and bio-incubators to support superior PRP preparation. Juventix also collaborates with prestigious organizations, including the University of South Florida (USF) Health Center for Advanced Medical Learning and Simulation (CAMLS), to host advanced clinical training symposiums.
For more information, visit www.Juventix.com or contact:
More on illi News
- Security Alert: TZNXG Warns Investors About "Fund Recovery" Scams
- HeartcoR Solutions Expands Suite of Remote Patient Monitoring Devices, Creating a One-Stop Shop for Clinical Trial Partners
- Assent Unveils Extended Producer Responsibility Packaging Solution to Simplify Compliance with Expanding Packaging Laws
- KatalisCoin: "Too Secure" for Bad Actors - Platform Embraces "Excessive Compliance" Criticism
- Keyanb Exchange Implements Enhanced Security Protocols Amid Industry-Wide Trust Challenges
📞 (866) 693-4777
✉️ Email: hello@juventix.com
Restore, Revive, Regenerate – Juventix Regenerative Medical.
Source: Juventix Regenerative Medical, LLC
0 Comments
Latest on illi News
- Leading Digital Finance Platform YNQTL Launches Revolutionary Web3 Digital Asset Trading Platform
- IDCXS Addresses Crypto Trading Pain Points with 2 Million TPS Processing and Multi-Layer Security Architecture
- Bridging Traditional Finance and Web3 Innovation: BLFCW Announces Strategic Vision for Regulated Web3 Economy
- NKSCX Responds to "Coordinated Smear Campaign" as Anonymous Critics Emerge Following Regulatory Milestones
- Broadway Gala Honored Also an Italian
- $ONI Listed on MEXC as ONINO Powers Europe's Tokenization Engine Into Public Platform Launch
- AZETHIO Crypto Exchange Whitepaper Reveals MPC-Secured Infrastructure Processing 1.2 Million Transactions Per Second
- CELOXFI Platform Demonstrates Advanced Security Architecture and Regulatory Framework
- Work 365 Launches PV 3.0: The Keystone Power App for Microsoft CSPs
- Local consultant shows small businesses how to turn red tape into real money
- CU Aerospace DUPLEX Satellite headed to the ISS on SpaceX NG-23 Mission
- Tour Napa Like a Local: Vines of Napa Valley Wine Passport AKA Vine Pass Unlocks Hidden Gems
- Mather Goes Bold to Challenge Society's Views on Aging
- Dental Surgical Center Accepts Sedation Patients with Medicaid for MD, WV, PA and DC
- MooreSuccess Gaming Launches Digi 995: Color Protocol – A Futuristic Coloring Experience
- A New Era in Healthcare Marketing
- Chicago: Mayor Brandon Johnson Signs 'Right to Protest' Executive Order
- Sloan's Lake Dental Launches New Website to Enhance Patient Experience and Access to Modern Dental Care
- Only 3 Weeks Left till the Start of the OpenSSL Conference 2025
- InventHelp Inventor Develops Portable Sit-On-Scale (CLR-320)